Pulmonary embolism: incidence and outcomes in a twelve-year historical series, in Tuscany - Italy (2010-2021)
Keywords:
Pulmonary embolism, Incidence trends, Epidemiological analysis, Mortality determinants, Anticoagulant Drugs, Gender DifferencesAbstract
Background. Pulmonary embolism poses a global health concern. Administrative databases serve as valuable sources for broad epidemiological studies on the prevalence and incidence of major diagnoses or diseases. The primary scope is to provide up-to- date insights into Pulmonary Embolism incidence trends, examining shifts in management and outcomes.
Design. This retrospective observational study examines a 12-year dataset from hospitals in the Tuscany Region, covering the first two years of the Covid-19 pandemic.
Methods. Administrative data from residents aged 18 and older discharged from hospital between 2010 and 2021 were used for the analysis.
Results. Hospitalized pulmonary embolism incidence slightly declined from 2010 to 2019 (64.7 to 60.9 x 100,000; p=0.152). Males under 75 showed a higher incidence rate, while females had higher incidence rates in older age groups. In-hospital and 30-day mortality decreased from 2010 to 2019 (p=0.001 and 0.020 respectively). In 2020, 30-day mortality increased (12.4% vs 10.1%, p=0.029), while in-hospital mortality remained stable. One-year mortality was stable from 2010-2019 but increased in 2020 (32.6% vs 29.4%, p=0.037). Considering the multivariable model, one-year mortality is significantly associated with sex, age, and comorbidities.
Conclusions. Our study shows that Pulmonary Embolism persists as a relevant burden in Tuscany region, but with improvements in management over the past decade and a decisive change in pharmacological treatment. Gender-related differences emerge, highlighting the need for a gender-specific healthcare approach.
References
1. Dentali F, Ageno W, Pomero F, Fenoglio L, Squizzato A, Bonzini M. Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy. Thromb Haemost. 2016 Jan;115(2):399-405. doi: 10.1160/TH15-02-0172. Epub 2015 Sep 17. PMID: 26422774.
2. Bĕlohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013 Spring;18(2):129-38. PMID: 23940438; PMCID: PMC3718593.
3. Stein PD, Beemath A, Olson RE. Trends in the incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients. Am J Cardiol. 2005 Jun 15;95(12):1525-6. doi: 10.1016/j.amjcard.2005.02.030. PMID: 15950590.
4. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):370-2. doi: 10.1161/ATVBAHA.108.162545. PMID: 18296591; PMCID: PMC2873781.
5. ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to global disease burden. Thromb Res. 2014 Nov;134(5):931-8. doi: 10.1016/j.thromres.2014.08.014. Epub 2014 Oct 10. PMID: 25312343.
6. Konstantinides SV, Barco S, Lankeit M, Meyer G. Management of Pulmonary Embolism: An Update. J Am Coll Cardiol. 2016 Mar 1;67(8):976-990. doi: 10.1016/j.jacc.2015.11.061. PMID: 26916489.
7. Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med. 2011 May 9;171(9):831-7. doi: 10.1001/archinternmed.2011.178. PMID: 21555660; PMCID: PMC3140219.
8. Monreal M, Mahé I, Bura-Riviere A, Prandoni P, Verhamme P, Brenner B, et al. Pulmonary embolism: Epidemiology and registries. Presse Med. 2015 Dec;44(12 Pt 2):e377-83. doi: 10.1016/j.lpm.2015.10.006. Epub 2015 Nov 4. PMID: 26547675.
9. de Miguel-Díez J, Jiménez-García R, Jiménez D, Monreal M, Guijarro R, Otero R, et al. Trends in hospital admissions for pulmonary embolism in Spain from 2002 to 2011. Eur Respir J. 2014 Oct;44(4):942-50. doi: 10.1183/09031936.00194213. Epub 2014 Jul 3. PMID: 24993910.
10. Mazzali C, Paganoni AM, Ieva F, Masella C, Maistrello M, Agostoni O, et al; HF Data Project. Methodological issues on the use of administrative data in healthcare research: the case of heart failure hospitalizations in Lombardy region, 2000 to 2012. BMC Health Serv Res. 2016 Jul 8;16:234. doi: 10.1186/s12913-016-1489-0. PMID: 27391599; PMCID: PMC4939041.
11. Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011 Mar 15;173(6):676-82. doi: 10.1093/aje/kwq433. Epub 2011 Feb 17. PMID: 21330339.
12. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020 Jan 21;41(4):543-603. doi: 10.1093/eurheartj/ehz405. PMID: 31504429.
13. de Miguel-Diez J, Albaladejo-Vicente R, Lopez-de-Andres A, Hernández-Barrera V, Jiménez D, Monreal M, et al. Changing Trends in Hospital Admissions for Pulmonary Embolism in Spain from 2001 to 2018. J Clin Med. 2020 Oct 7;9(10):3221. doi: 10.3390/jcm9103221. PMID: 33036474; PMCID: PMC7599502.
14. Minges KE, Bikdeli B, Wang Y, Kim N, Curtis JP, Desai MM, et al. National Trends in Pulmonary Embolism Hospitalization Rates and Outcomes for Adults Aged ≥65 Years in the United States (1999 to 2010). Am J Cardiol. 2015 Nov 1;116(9):1436-42. doi: 10.1016/j.amjcard.2015.07.068. PMID: 26409636; PMCID: PMC4841688.
15. Schissler AJ, Rozenshtein A, Schluger NW, Einstein AJ. National trends in emergency room diagnosis of pulmonary embolism, 2001-2010: a cross-sectional study. Respir Res. 2015 Mar 24;16(1):44. doi: 10.1186/s12931-015-0203-9. PMID: 25890024; PMCID: PMC4391335.
16. Bikdeli B, Wang Y, Minges KE, Desai NR. Hospitalizations, Therapies, and Outcomes of Pulmonary Embolism in Medicare Beneficiaries: Trends Are Similar to Europe. J Am Coll Cardiol. 2016 May 31;67(21):2559-60. doi: 10.1016/j.jacc.2016.02.075. PMID: 27230057.
17. Huang W, Goldberg RJ, Anderson FA, Kiefe CI, Spencer FA. Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009). Am J Med. 2014 Sep;127(9):829-39.e5. doi: 10.1016/j.amjmed.2014.03.041. PMID: 24813864; PMCID: PMC4161646.
18. Abou-Ismail MY, Citla Sridhar D, Nayak L. Estrogen and thrombosis: A bench to bedside review. Thromb Res. 2020 Aug;192:40-51. doi: 10.1016/j.thromres.2020.05.008. PMID: 32450447; PMCID: PMC7341440.
19. Eskes T, Haanen C. Why do women live longer than men? Eur J Obstet Gynecol Reprod Biol. 2007 Aug;133(2):126-33. doi: 10.1016/j.ejogrb.2007.01.006. PMID: 17324494.
20. Deitelzweig SB, Johnson BH, Lin J, Schulman KL. Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am J Hematol. 2011 Feb;86(2):217-20. doi: 10.1002/ajh.21917. PMID: 21264912.
21. Engbers MJ, van Hylckama Vlieg A, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost. 2010 Oct;8(10):2105-12. doi: 10.1111/j.1538-7836.2010.03986.x. PMID: 20629943.
22. Spencer FA, Emery C, Joffe SW, Pacifico L, Lessard D, Reed G, et al. Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J Thromb Thrombolysis. 2009 Nov;28(4):401-9. doi: 10.1007/s11239-009-0378-3. PMID: 19629642; PMCID: PMC3248815.
23. Keller K, Hobohm L, Ebner M, Kresoja KP, Münzel T, Konstantinides SV, et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J. 2020 Jan 21;41(4):522-529. doi: 10.1093/eurheartj/ehz236. PMID: 31102407.
24. Pauley E, Orgel R, Rossi JS, Strassle PD. Age-Stratified National Trends in Pulmonary Embolism Admissions. Chest. 2019 Oct;156(4):733-742. doi: 10.1016/j.chest.2019.05.021. PMID: 31233745.
25. Barco S, Lankeit M, Binder H, Schellong S, Christ M, Beyer-Westendorf J, et al. Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial. Thromb Haemost. 2016 Jul 4;116(1):191-7. doi: 10.1160/TH16-01-0004. Epub 2016 Mar 24. PMID: 27010343.
26. Vinson DR, Ballard DW, Huang J, Reed ME, Lin JS, Kene MV, et al; MAPLE Investigators of the KP CREST Network. Outpatient Management of Emergency Department Patients With Acute Pulmonary Embolism: Variation, Patient Characteristics, and Outcomes. Ann Emerg Med. 2018 Jul;72(1):62-72.e3. doi: 10.1016/j.annemergmed.2017.10.022. Epub 2017 Dec 13. PMID: 29248335.
27. Barco S, Schmidtmann I, Ageno W, Bauersachs RM, Becattini C, Bernardi E, et al; HoT-PE Investigators. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial. Eur Heart J. 2020 Jan 21;41(4):509-518. doi: 10.1093/eurheartj/ehz367. PMID: 31120118.
28. Mastroiacovo D, Dentali F, di Micco P, Maestre A, Jiménez D, Soler S, et al. Rate and duration of hospitalization for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry. Eur Respir J. 2019 Feb 21;53(2):1801677. doi: 10.1183/13993003.01677-2018. PMID: 30578388.
29. Eck RJ, Elling T, Sutton AJ, Wetterslev J, Gluud C, van der Horst ICC, et al. Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysis. BMJ. 2022 Jul 4;378:e070022. doi: 10.1136/bmj-2022-070022. PMID: 35788047; PMCID: PMC9251634.
30. Najjar-Debbiny R, Chazan B, Lobl R, Greene MT, Ratz D, Saint S, et al; Israel IPC Working Group. Healthcare-associated infection prevention and control practices in Israel: results of a national survey. BMC Infect Dis. 2022 Sep 16;22(1):739. doi: 10.1186/s12879-022-07721-8. PMID: 36114529; PMCID: PMC9482296.
31. Swan D, Hitchen S, Klok FA, Thachil J. The problem of under-diagnosis and over-diagnosis of pulmonary embolism. Thromb Res. 2019 May;177:122-129. doi: 10.1016/j.thromres.2019.03.012. Epub 2019 Mar 14. PMID: 30889517.
32. Barco S, Mahmoudpour SH, Valerio L, Klok FA, Münzel T, Middeldorp S, et al. Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database. Lancet Respir Med. 2020 Mar;8(3):277-287. doi: 10.1016/S2213-2600(19)30354-6. Epub 2019 Oct 12. PMID: 31615719.
33. Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Müller MCA, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27. PMID: 32369666; PMCID: PMC7497052.
34. Trevisan C, Noale M, Zatti G, Vetrano DL, Maggi S, Sergi G. Hospital length of stay and 30-day readmissions in older people: their association in a 20-year cohort study in Italy. BMC Geriatr. 2023 Mar 21;23(1):154. doi: 10.1186/s12877-023-03884-4. PMID: 36941535; PMCID: PMC10029164.
35. Jiménez D, de Miguel-Díez J, Guijarro R, Trujillo-Santos J, Otero R, Barba R, et al; RIETE Investigators. Trends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE Registry. J Am Coll Cardiol. 2016 Jan 19;67(2):162-170. doi: 10.1016/j.jacc.2015.10.060. PMID: 26791063.
36. Lauque D, Khalemsky A, Boudi Z, Östlundh L, Xu C, Alsabri M, et al. Length-of-Stay in the Emergency Department and In-Hospital Mortality: A Systematic Review and Meta-Analysis. J Clin Med. 2022 Dec 21;12(1):32. doi: 10.3390/jcm12010032. PMID: 36614835; PMCID: PMC9821325.
37. Douketis JD, Gu CS, Schulman S, Ghirarduzzi A, Pengo V, Prandoni P. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med. 2007 Dec 4;147(11):766-74. doi: 10.7326/0003-4819-147-11-200712040-00007. PMID: 18056660.
38. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA. 1998 Feb 11;279(6):458-62. doi: 10.1001/jama.279.6.458. PMID: 9466640.
39. Kearon C. Natural history of venous thromboembolism. Circulation. 2003 Jun 17;107(23 Suppl 1):122-30. doi: 10.1161/01.CIR.0000078464.82671.78. PMID: 12814982.
40. Carson JL, Kelley MA, Duff A, Weg JG, Fulkerson WJ, Palevsky HI, et al. The clinical course of pulmonary embolism. N Engl J Med. 1992 May 7;326(19):1240-5. doi: 42.10.1056/NEJM199205073261902. PMID: 1560799.
41. Ng AC, Chow V, Yong AS, Chung T, Kritharides L. Prognostic impact of the Charlson comorbidity index on mortality following acute pulmonary embolism. Respiration. 2013;85(5):408-16. doi: 10.1159/000342024. Epub 2012 Nov 10. PMID: 23147354.
42. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999 Apr 24;353(9162):1386-9. doi: 10.1016/s0140-6736-(98)07534-5. PMID: 10227218.
43. Heckbert SR, Kooperberg C, Safford MM, Psaty BM, Hsia J, McTiernan A, et al. Comparison of Self-Report, Hospital Discharge Codes, and Adjudication of Cardiovascular Events in the Women’s Health Initiative. Am J Epidemiol. 2004 Dec 15;160(12):1152-8. doi: 10.1093/aje/kwh314. PMID: 15583367.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Gabriele Cerini, Carla Lunetta, Claudia Szasz, Leonardo Misurarca, Fabrizio Gemmi, Marisa Carluccio, Chiara Lorini, Guglielmo Bonaccorsi, Silvia Forni (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.